Literature DB >> 7576823

Ochratoxin A in human blood in relation to nephropathy in Tunisia.

K Maaroufi1, A Achour, M Hammami, M el May, A M Betbeder, F Ellouz, E E Creppy, H Bacha.   

Abstract

The determination of ochratoxin A (OTA) in human blood in Tunisian populations is underway. The range of contamination is between 0.7 to 7.8 ng ml-1 for the general population and 12 to 55 ng ml-1 for people suffering from chronic renal failure. It appears that 21 to 64% of people suffering from nephropathy are OTA positive with a detection limit of 1ng ml-1. This situation prompted us to search for possible association of OTA contamination and nephropathy resembling Balkan endemic nephropathy. The classification of the ill population into chronic interstitial nephropathy (CIN), chronic glomerular nephropathy (CGN), chronic vascular nephropathy (CVN) and others, indicated that the largest is the CIN group which is significantly different from the other groups, and from the control (P < 0.005). Furthermore, it presented the highest OTA mean values (25 to 59 ng ml-1) compared with the control, CGN, CVN and other groups (6 to 18 ng ml-1) according to the designated region in Tunisia. The rural population seems to be more exposed to ochratoxins in Tunisia, as has been previously reported in the Balkans and Western Europe. Altogether, these results emphasise that in Tunisia an endemic ochratoxin-related nephropathy is probably occurring.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576823     DOI: 10.1177/096032719501400710

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  16 in total

1.  The effects of season and gender on the serum aflatoxins and ochratoxin A levels of healthy adult subjects from the Central Anatolia Region, Turkey.

Authors:  Suna Sabuncuoglu; Pinar Erkekoglu; Sevtap Aydin; Gönül Şahin; Belma Kocer-Gumusel
Journal:  Eur J Nutr       Date:  2014-07-25       Impact factor: 5.614

2.  Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high-performance liquid chromatography.

Authors:  M Pascale; A Visconti
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 3.  Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Mami Osawa; Ayumi Sanpei; Shun Fujimaki
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

4.  Implications of fungal infections and mycotoxins in camel diseases in Saudi Arabia.

Authors:  Fardos M Bokhari
Journal:  Saudi J Biol Sci       Date:  2010-01       Impact factor: 4.219

5.  Preliminary results on Ochratoxin A concentrations in blood of patients with various kidney diseases in Germany.

Authors:  G Schwerdt; C Schuster; S Silbernagl; M Gareis; M Gekle
Journal:  Mycotoxin Res       Date:  2001-06       Impact factor: 3.833

6.  Ochratoxin A in human blood serum - retrospective long-term data.

Authors:  Erwin Märtlbauer; Ewald Usleber; Richard Dietrich; Elisabeth Schneider
Journal:  Mycotoxin Res       Date:  2009-09-15       Impact factor: 3.833

7.  Inhibition of the mitogen activated protein kinase ERK1/2 amplifies ochratoxin A toxicity in the proximal tubule of the kidney.

Authors:  C Sauvant; H Holzinger; M Gekle
Journal:  Mycotoxin Res       Date:  2003-06       Impact factor: 3.833

Review 8.  The involvement of mycotoxins in the development of endemic nephropathy.

Authors:  Maja Peraica; Ana-Marija Domijan; Marica Miletić-Medved; Radovan Fuchs
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 9.  Ochratoxin A in Moroccan foods: occurrence and legislation.

Authors:  Abdellah Zinedine
Journal:  Toxins (Basel)       Date:  2010-05-14       Impact factor: 4.546

Review 10.  A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis.

Authors:  Janette H Hope; Bradley E Hope
Journal:  J Environ Public Health       Date:  2011-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.